Published November 29, 2006 | https://doi.org/10.63485/h3q7r-s6d12

The MRC's new FAQ on its OA policy

Creators & Contributors

The UK's Medical Research Council (MRC) has launched an FAQ on OA.  There are some new points here even for those who have been following the evolution of the MRC's OA policy.  For example, the MRC will use the Bethesda definition of OA (Question 1).  It will also follow the Wellcome Trust in using a strict mandate:  grantees who want to publish in journals that don't permit OA archiving on the MRC's terms, including the maximum six month embargo, must negotiate with the journal or publish elsewhere (Question 9), although they may petition MRC to make a rare exception (Question 15).

Comment.  Kudos to the MRC for using the Wellcome-type mandate that doesn't let publishers set the embargo period.  As I've argued before, the legal basis of funder OA policies should be the enforceable funding contract (or a specially enacted government license), not the consent of a third party like the grantee's publisher.

Files

10.63485_h3q7r-s6d12.pdf

Files (96.0 kB)

Name Size Download all
md5:764b0879ef0663296480a5f4ef3c0dcb
96.0 kB Preview Download

Additional details

Description

The UK's Medical Research Council (MRC) has launched an FAQ on OA. There are some new points here even for those who have been following the evolution of the MRC's OA policy. For example, the MRC will use the Bethesda definition of OA (Question 1). It will also follow the Wellcome Trust in using a strict mandate:

Identifiers

GUID
tag:blogger.com,1999:blog-3536726.post-116482931761748616
URL
https://legacy.earlham.edu/~peters/fos/2006/11/mrcs-new-faq-on-its-oa-policy.html

Dates

Issued
2006-11-29T00:00:00Z
Updated
2006-11-29T20:04:59Z